Search

Search Results

• Analysis of the effects of immunotherapy depending on cancer subtypes on survival - a single center experience

  Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Kacper Ponikowski, Paulina Gumółka, Karol Jakubik, Mikołaj Jeżak, Agnieszka Kalicińska, Angelika Doroszewska, Mariola Janiszewska, Katarzyna Szklener

  56084

  2024-11-27
• Targeted Therapy in NSCLC: A Comprehensive Review of Molecular Drivers and Treatment Strategies

  Valeryia Milasheuskaya, Katsiaryna Miraniuk, Mykola Sobchynskyi , Andrii Myrnyi , Dmytro Kowalczuk , Viktoryia Kasianik , Darya Lazitskaya , Kamil Turlej , Iga Kiełbaszewska , Natalia Surosz , Dawid Wiczkowski

  61191

  2025-07-01
• Optimal First-Line Use of Pembrolizumab in Metastatic Driver-Negative NSCLC: Monotherapy Versus Chemo-Immunotherapy (Evidence 2022–2025)

  Patryk Bachurski, Gabriela Chmiel, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Wiśniewski, Paweł Witkowski, Bartosz Zarański

  68252

  2026-01-31
• Emerging Directions in CAR-T Cell Therapy: Solid Tumors

  Michał Magiera, Miłosz Sikora, Piotr Czwałga, Patrycja Koprowska

  67441

  2026-01-05